Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D

NCT05847413 EARLY_PHASE1 COMPLETED

The purpose of this study is to determine whether verapamil can transiently improve beta cell function in those who do or do not secrete proinsulin and little/no C-peptide.

Details

Lead sponsor	Benaroya Research Institute
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	10
Start date	Sat May 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Type 1 Diabetes

Interventions

• Verapamil

Countries

United States